DK1146906T3 - Mukosalt afgivelsessystem - Google Patents
Mukosalt afgivelsessystemInfo
- Publication number
- DK1146906T3 DK1146906T3 DK00901497.8T DK00901497T DK1146906T3 DK 1146906 T3 DK1146906 T3 DK 1146906T3 DK 00901497 T DK00901497 T DK 00901497T DK 1146906 T3 DK1146906 T3 DK 1146906T3
- Authority
- DK
- Denmark
- Prior art keywords
- compositions
- vaccines
- formulations
- methods
- well
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 5
- 238000009472 formulation Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000282414 Homo sapiens Species 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002452 interceptive effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Vending Machines For Individual Products (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11889699P | 1999-02-05 | 1999-02-05 | |
| DKPA199900155 | 1999-02-05 | ||
| PCT/DK2000/000049 WO2000045847A1 (en) | 1999-02-05 | 2000-02-04 | Novel mucosal delivery system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1146906T3 true DK1146906T3 (da) | 2011-10-24 |
Family
ID=26063341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00901497.8T DK1146906T3 (da) | 1999-02-05 | 2000-02-04 | Mukosalt afgivelsessystem |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1146906B1 (enExample) |
| JP (1) | JP2003517452A (enExample) |
| CN (1) | CN1338947B (enExample) |
| AT (1) | ATE515258T1 (enExample) |
| AU (1) | AU771552B2 (enExample) |
| CA (1) | CA2361377C (enExample) |
| DK (1) | DK1146906T3 (enExample) |
| ES (1) | ES2368987T3 (enExample) |
| HK (1) | HK1041219B (enExample) |
| WO (1) | WO2000045847A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020051794A1 (en) | 2000-08-09 | 2002-05-02 | Alk-Abello A/S | Novel parenteral vaccine formulations and uses thereof |
| DE60139404D1 (de) * | 2000-08-09 | 2009-09-10 | Alk Abello As | Parenterale impfstoff-formulierungen und deren verwendung |
| AU2004203772B2 (en) * | 2003-01-07 | 2009-07-16 | Yeda Research And Development Co. Ltd. | Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| US20060115499A1 (en) * | 2004-09-27 | 2006-06-01 | Alk-Abello A/S | Liquid allergy vaccine formulation for oromucosal administration |
| JP5628473B2 (ja) * | 2004-11-10 | 2014-11-19 | アルク−アベッロ エイ／エスＡｌｋ−Ａｂｅｌｌｏ Ａ／Ｓ | アレルギーワクチンの粘膜投与によるアレルギーの予防治療方法 |
| AU2006299310A1 (en) * | 2005-10-04 | 2007-04-12 | Alk-Abello A/S | Solid vaccine formulation |
| BRPI0618241A2 (pt) * | 2005-11-04 | 2011-08-23 | Alk Abello As | uso de um alérgeno para fabricação de uma formulação de vacina lìquida para prevenção ou tratamento de alergia |
| EP1814516B1 (en) * | 2005-11-04 | 2012-12-26 | Alk-Abelló A/S | Use of a liquid allergy vaccine formulation for oromucosal administration |
| WO2009142772A2 (en) * | 2008-05-23 | 2009-11-26 | Mastcell Pharmaceuticals, Inc. | Methods and treatment for allergies and inflammation associated with gastrointestinal diseases |
| CN102441162B (zh) * | 2010-10-04 | 2018-07-24 | 免疫产品美国股份有限公司 | 结核病的治疗和预防 |
| EP3556398A1 (en) * | 2018-04-16 | 2019-10-23 | Croda Denmark A/S | Phytates for use as a biomolecules delivery or adsorption system |
| MX2021014936A (es) * | 2019-06-11 | 2022-01-24 | Glaxosmithkline Biologicals Sa | Formulaciones de vacunas a traves de la mucosa. |
| CN111658611B (zh) * | 2020-04-13 | 2021-06-01 | 四川大学 | 一种基于微乳的疫苗递送系统及其制备方法和应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3329564A (en) | 1965-06-28 | 1967-07-04 | Parke Davis & Co | Antacid preparations and means of producing the same |
| DE2126957B2 (de) | 1971-05-29 | 1977-07-07 | Schettler, Hermann, Dr, East Lan sing, Mich (VStA) | Verfahren zur herstellung von impfstoffen gegen gaensehepatitis |
| US4233288A (en) * | 1979-03-12 | 1980-11-11 | Cornell John A | Gum emulsified liquid package for delivering and preserving liquid content in the mouth |
| JPS61238728A (ja) | 1985-04-16 | 1986-10-24 | Mitsui Norin Kk | 茶葉抽出物と活性水酸化アルミニウムとの抗潰瘍性複合体 |
| IL84167A (en) | 1986-10-24 | 1991-04-15 | Southern Res Inst | Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation |
| JPH02124832A (ja) * | 1988-07-08 | 1990-05-14 | Toray Ind Inc | インターヘェロンβ組成物 |
| US5443832A (en) * | 1990-04-16 | 1995-08-22 | Institut Swisse De Recherches Experimentales Sur Le Cancer | Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response |
| JP3132863B2 (ja) * | 1991-10-24 | 2001-02-05 | 富山化学工業株式会社 | 徐放性口腔用軟膏 |
| US5360792A (en) | 1991-12-20 | 1994-11-01 | Greenwich Pharmaceuticals Incorporated | Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom |
| US5972336A (en) * | 1992-11-03 | 1999-10-26 | Oravax Merieux Co. | Urease-based vaccine against helicobacter infection |
| AU6414994A (en) | 1993-03-18 | 1994-10-11 | Cytimmune Sciences, Inc. | Composition and method for reducing toxicity of biologically-active factors |
| GB9316745D0 (en) | 1993-08-12 | 1993-09-29 | Medeva Holdings Bv | Vaccine compositions |
| JP3414539B2 (ja) * | 1994-05-11 | 2003-06-09 | 有限会社ドット | 経鼻吸収用組成物 |
| JP2001515457A (ja) * | 1995-06-07 | 2001-09-18 | アルカームズ コントロールド セラピューティックス，インコーポレイテッド | 凝集安定化生理活性物質放出用装置 |
| US6221365B1 (en) * | 1996-07-26 | 2001-04-24 | American Cyanamid Company | NucA protein of Haemophilus influenzae |
| WO1998040100A1 (en) * | 1997-03-10 | 1998-09-17 | Ottawa Civic Loeb Research Institute | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT |
| DE69822542T2 (de) * | 1997-04-23 | 2004-08-05 | Pfizer Inc. | Verkapslung einer Untereinheit des Bovinen Herpes Virus Typ-1 in wässrigen Lösungsmitteln als Impfstoff. |
| JPH11216357A (ja) * | 1998-02-03 | 1999-08-10 | Tsutsumi Techno Planning Kk | 生理活性物質用の吸着担体 |
| JPH11286438A (ja) * | 1998-03-31 | 1999-10-19 | Shiseido Co Ltd | 徐放性製剤 |
| JPH11302184A (ja) * | 1998-04-21 | 1999-11-02 | Taisho Pharmaceut Co Ltd | 点鼻用組成物 |
| JPH11322582A (ja) * | 1998-05-06 | 1999-11-24 | Dot:Kk | 経鼻吸収用鼻粘膜付着・滞留型キャリヤ |
-
2000
- 2000-02-04 CA CA002361377A patent/CA2361377C/en not_active Expired - Fee Related
- 2000-02-04 ES ES00901497T patent/ES2368987T3/es not_active Expired - Lifetime
- 2000-02-04 DK DK00901497.8T patent/DK1146906T3/da active
- 2000-02-04 EP EP00901497A patent/EP1146906B1/en not_active Expired - Lifetime
- 2000-02-04 AU AU22797/00A patent/AU771552B2/en not_active Ceased
- 2000-02-04 AT AT00901497T patent/ATE515258T1/de not_active IP Right Cessation
- 2000-02-04 CN CN008034524A patent/CN1338947B/zh not_active Expired - Fee Related
- 2000-02-04 HK HK02102996.8A patent/HK1041219B/en not_active IP Right Cessation
- 2000-02-04 JP JP2000596966A patent/JP2003517452A/ja not_active Withdrawn
- 2000-02-04 WO PCT/DK2000/000049 patent/WO2000045847A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ATE515258T1 (de) | 2011-07-15 |
| WO2000045847A8 (en) | 2010-12-02 |
| EP1146906A1 (en) | 2001-10-24 |
| JP2003517452A (ja) | 2003-05-27 |
| EP1146906B1 (en) | 2011-07-06 |
| AU771552B2 (en) | 2004-03-25 |
| HK1041219B (en) | 2011-10-21 |
| HK1041219A1 (en) | 2002-07-05 |
| CA2361377A1 (en) | 2000-08-10 |
| WO2000045847A1 (en) | 2000-08-10 |
| CN1338947A (zh) | 2002-03-06 |
| CN1338947B (zh) | 2012-11-14 |
| AU2279700A (en) | 2000-08-25 |
| ES2368987T3 (es) | 2011-11-24 |
| CA2361377C (en) | 2009-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1146906T3 (da) | Mukosalt afgivelsessystem | |
| CY1110727T1 (el) | Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση | |
| CY1106602T1 (el) | Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων | |
| NZ331651A (en) | BSW17 peptide immunogens for vaccination against and treatment of allergy | |
| ATE163913T1 (de) | Ungesättigte aliphatische dicarbonsäuren | |
| WO2003055513A3 (en) | Bacillus subtilis spores to stimulate the immune responses | |
| GB0109297D0 (en) | Vaccine | |
| PT1409692E (pt) | Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina | |
| DE69714011D1 (de) | Die erzeugung einer immunantwort gegen erwünschte determinanten | |
| BR0206312A (pt) | Composição de vacina, uso sobrenadante de cultura celular de escherichia coli enteroemorrágica (ehec), e, métodos para a geração de uma resposta imunológica em um mamìfero contra um antìgeno de escherichia coli enteroemorrágica (ehec) secretado, e 0157:h7 enteroemorrágica (ehec 0157:h7) secretado, e para a redução da colonização de escherichia coli enteroemorrágica (ehec) em um ruminante | |
| IS7296A (is) | Bóluefni og aðferð við meðhöndlun á hreyfitaugungahrörnun | |
| MXPA02005563A (es) | Formulacion estable de interferon en solucion acuosa, metodo de preparacion y usos de la misma. | |
| AU1813701A (en) | Interleukin-1 muteins useful as vaccine adjuvants | |
| ATE399022T1 (de) | Zusammensetzung und verfahren zur verstärkung der immunantwort antigen-präsentierender zellen | |
| EP1471936A4 (en) | HIV VACCINE AND METHOD OF USE | |
| DE69418183D1 (de) | Immunotherapeutische zubereitung | |
| WO1997005899A3 (en) | Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same | |
| WO2000045849A3 (en) | Use of cationic lipids to generate anti-tumor immunity | |
| AU1815899A (en) | Method and composition to enhance the efficacy of a vaccine using chemokines | |
| WO2002058535A3 (en) | Use of combretastatin a4 and its prodrugs as an immune enhancing therapy | |
| AU3808795A (en) | Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal product and their intended use in anticancer treatments | |
| DE50014268D1 (de) | Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen | |
| MY137709A (en) | Method for obtaining antigenic structures of high cross reactivity and their use in formulations | |
| AU6942896A (en) | Use of muteins of wild-type cytokines as immunogens | |
| EP0836480A4 (en) | COMPOSITIONS THAT PROVIDE ADP-RIBOSYL TRANSFERASE ACTIVITY AND METHODS FOR THEIR PRODUCTION AND USE |